Impact of Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- Other: Delayed oncological supportive careOther: Early oncological supportive care
- Registration Number
- NCT05355987
- Lead Sponsor
- Centre Henri Becquerel
- Brief Summary
Multiple myeloma is the second most frequent hematologic malignancy, which incidence augmented between 1995 and 2018, with an annual mean variation of +0.6% to 1.1%. Although treatment improved in the last years, the patients' prognostic is associated with cytogenetic abnormalities.
Oncological supportive care provides patients with a global perspective, in addition to specific medical treatment adapted to pathology and patient profile. It contributes to the improvement of quality of life of patients, throughout their care pathway regarding physical, psychological and social aspects, according to their specific needs as well as their caregivers'.
The aim of this study is to evaluate the quality of life at 6 months after multiple myeloma diagnosis in outpatients receiving paramedical consultations in oncological supportive care from the diagnosis versus outpatients receiving paramedical consultations in oncological supportive care after 6 months after diagnosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 50
- Age superior to 18 years old
- Patient recently diagnosed with multiple myeloma not eligible to autologous blood stem-cell transplantation, before starting therapy in day hospital
- Patient coming regularly to Centre Henri Becquerel for treatment and follow up for multiple myeloma
- Informed consent form signed
- Inclusion Criteria:
- Age superior to 18 years old
- Patient recently diagnosed with multiple myeloma not eligible to autologous blood stem-cell transplantation, before starting therapy in day hospital
- Patient coming regularly to Centre Henri Becquerel for treatment and follow up for multiple myeloma
- Informed consent form signed
Exclusion Criteria:
- Patient with urgent need of treatment after multiple myeloma diagnosis with urgent and absolute need of oncological supportive care immediately after diagnosis
- Patient deprived of liberty, under judicial supervision, under guardianship or trusteeship
- History of psychological or sensorial disorder or anomaly that can prevent the patient from understanding the conditions for study participation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Delayed oncological supportive care Delayed oncological supportive care Evaluation of needs in oncological supportive care by a nursing coordinator at 6 months after diagnosis and recommendation to plan appointments with different specialists in supportive care regarding to patient's needs Early oncological supportive care Early oncological supportive care Evaluation of needs in oncological supportive care by a nursing coordinator from diagnosis and recommendation to plan appointments with different specialists in supportive care regarding to patient's needs
- Primary Outcome Measures
Name Time Method Comparison of quality of life evolution in outpatients with multiple myeloma between the two groups 6 months Comparison of the score obtained with Functional Assessment of Cancer Therapy- Multiple Myeloma questionnary
- Secondary Outcome Measures
Name Time Method Qualitative evaluation of quality of life 6 months Semi-structured individual interviews
Comparison of quality of life in outpatients with multiple myeloma between the two groups 9 months Comparison of the score obtained with Functional Assessment of Cancer Therapy- Multiple Myeloma questionnary
Comparison of autonomy evolution in outpatients with multiple myeloma between the two groups 6 months Comparison of the score of Instrument Activities of daily Living questionnary
Trial Locations
- Locations (1)
Centre Henri Becquerel
🇫🇷Rouen, France